New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 24, 2014
11:07 EDTVRTX, JBL, MU, ADBE, RAD, RHT, PIR, SWHC, MTOR, APDOptions with decreasing implied volatility
Options with decreasing implied volatility: VRTX MTOR SWHC PIR RHT RAD ADBE MU JBL APD
News For VRTX;MTOR;SWHC;PIR;RHT;RAD;ADBE;MU;JBL;APD From The Last 14 Days
Check below for free stories on VRTX;MTOR;SWHC;PIR;RHT;RAD;ADBE;MU;JBL;APD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
September 9, 2014
07:22 EDTMURaymond James to hold a conference
North American Equities Conference to be held in London, England on September 9.
September 8, 2014
11:05 EDTRHT, VRTXOptions with increasing implied volatility
Options with increasing implied volatility: NPSP GILD VNET AVNR GTAT YHOO RHT VRTX SDRL COV MYL
September 5, 2014
11:47 EDTRHTOptions with increasing implied volatility
Subscribe for More Information
11:32 EDTADBEApple, Google, Adobe appeal court's rejection of hiring settlement, Reuters says
Subscribe for More Information
10:05 EDTVRTXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:41 EDTVRTXVertex upgraded to Buy from Neutral at Goldman
Goldman Sachs upgraded Vertex Pharmaceuticals to Buy saying it sees a 90% probability of approval for the company's VX-809/Kalydeco combo for cystic fibrosis and a higher likelihood of M&A following the positive Phase 3 data in June. Goldman raised its price target for shares to $131 from $109.
September 4, 2014
12:50 EDTMUMicron's Adams says market different now due to consolidation, diversification
Subscribe for More Information
11:05 EDTRHTOptions with increasing implied volatility
Subscribe for More Information
10:32 EDTRHTCisco, Red Hat expand relationship, launch solution for OpenStack
Subscribe for More Information
09:10 EDTRHTBarclays' top ideas in U.S. Software for 2H 2014
Subscribe for More Information
08:31 EDTRADRite Aid reports August SSS up 3.9%
For the five weeks ended Aug. 30, 2014, same store sales increased 3.9% over the prior-year period. August front-end same store sales increased 1.1%. Pharmacy same store sales, which included an approximate 219 basis points negative impact from new generic introductions, increased 5.2%. Prescription count at comparable stores increased 3.7%over the prior-year period. Total drugstore sales for the five-week period increased 3.7% to $2.515B compared to $2.425B for the same period last year. Prescription sales accounted for 69.3% of drugstore sales, and third party prescription sales represented 97.5% of pharmacy sales. Same store sales for the 13-week period ended Aug. 30, 2014 increased 4.1% over the prior-year period. Front-end same store sales increased 1.1% while pharmacy same store sales increased 5.6 percent. Prescription count at comparable stores increased 3.7% over the prior-year period.
06:53 EDTMUMicron reinstated with a Buy at Deutsche Bank
Deutsche Bank reinstated shares of Micron with a Buy rating saying the company's improved profitability and free cash flow generation are sustainable. The firm has a $40 price target for shares.
06:40 EDTADBEApple, others restart discussions with tech staff in hiring suit, Reuters says
Subscribe for More Information
06:03 EDTRADStocks with implied volatility movement; WAG RAD
Subscribe for More Information
05:26 EDTAPDTechnip awarded contract by Air Products in Kochi, India
Subscribe for More Information
September 3, 2014
12:19 EDTRHTOptions with increasing implied volatility
Subscribe for More Information
11:07 EDTSWHCOptions with decreasing implied volatility
Subscribe for More Information
10:52 EDTRHTRed Hat September volatility increases into Q2 and outlook
Red Hat September call option implied volatility is at 47, October is at 32, December is at 29; compared to its 26-week average of 32 according to Track Data, suggesting large near term price movement into the expected release of Q2 results after the market close on September 18.
09:43 EDTSWHCSmith & Wesson repeats FY15 revenue view $530M-$540M, consensus $532.06M
Subscribe for More Information
09:29 EDTMUMicron, SanDisk have positive read though from Samsung proxy, says Sterne Agee
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use